Dr. Falk Pharma GmbH

Who: Takeda/Innate Pharma What: Takeda is licensing antibodies discovered by Innate for use in antibody-drug conjugate therapeutics for celiac disease. Why: Celiac disease is a major focus of Tak

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. $50m Taysha Investment Gives Astel

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Alliances With F-star And Xencor Featur

The US presidential election slowed the flow of venture capital funding announcements during the first week of November, but the flood of new biopharmaceutical VC deals resumed during the second week